Systematic reviews on peri-implant diseases often disagree on risk of bias, highlighting need for standardized assessment.
The article compares two tools used to evaluate reviews on treating peri-implant diseases. They found that most reviews had a high risk of bias, and some had low methodological quality. The ROBIS tool was more critical than the AMSTAR checklist. Different reviews disagreed on the risk of bias for the same studies.